Atopic Dermatitis Bulk Plasma

Atopic Dermatitis Bulk Plasma Collected via Apheresis in ACDA

Atopic Dermatitis Plasma is collected from IRB-consented donors diagnosed with Atopic Dermatitis, using apheresis and ACDA (Acid-Citrate-Dextrose Formula A) as the anticoagulant. This disease-state plasma supports immunological and biomarker research and is ideal for assay development and therapeutic discovery.

Product Features

  • High-volume plasma collected via apheresis
  • Anticoagulated using ACDA
  • Tested and confirmed negative for HIV, HBV, and HCV
  • Available fresh with custom volumes upon request
  • IRB-approved informed consent and HIPAA-compliant handling

De-identified Donor Data

  • Clinically confirmed diagnosis of Atopic Dermatitis
  • Donor demographics: age, sex assigned at birth, race/ethnicity
  • Clinical history and medication data available

Applications

  • Disease-specific biomarker discovery
  • Inflammatory and immunological assay development
  • Proteomic, metabolomic, and cytokine profiling
  • Therapeutic development and validation studies

Compliance and Quality Assurance

  • Screened negative for HIV, HBV, and HCV
  • IRB-approved collection with 21 CFR Part 11–compliant consent
  • Standardized processing and cryopreservation protocols

Ordering & Customization

Atopic Dermatitis Bulk Plasma is available in standard or custom volumes. For documentation or international shipping, please contact learnmore@sanguinebio.com.

Frequently Asked Questions

Showing 1–12 of 24 results

Are samples IRB approved?

1 Answer

YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.

YES – with the exception of GMP leukopaks, all our products are research use only (RUO).

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

YES – Unique donors can be specified and guaranteed based on your requirements.

For information about sample quality, please see: Quality and Compliance

YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

1 2
×

Ask a Question

Need a custom Bulk Plasma cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information